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Abstract
Background: Few investigations have assessed risk behaviours and social-structural contexts of risk among
injecting drug users (IDUs) in Northeast India, where injecting drug use is the major route of HIV transmission.
Investigations of risk environments are needed to inform development of effective risk reduction interventions.
Methods: This mixed methods study of HIV-positive IDUs in Manipur included a structured survey (n = 75), two
focus groups (n = 17), seven in-depth interviews, and two key informant interviews.
Results: One-third of survey participants reported having shared a needle/syringe in the past 30 days; among
these, all the men and about one-third of the women did so with persons of unknown HIV serostatus. A variety of
social-structural contextual factors influenced individual risk behaviours: barriers to carrying sterile needles/syringes
due to fear of harassment by police and “anti-drug” organizations; lack of sterile needles/syringes in drug dealers’
locales; limited access to pharmacy-sold needles/syringes; inadequate coverage by needle and syringe programmes
(NSPs); non-availability of sterile needles/syringes in prisons; and withdrawal symptoms superseding concern for
health. Some HIV-positive IDUs who shared needles/syringes reported adopting risk reduction strategies: being the
‘last receiver’ of needles/syringes and not a ‘giver;’ sharing only with other IDUs they knew to be HIV-positive; and,
when a ‘giver,’ asking other IDUs to wash used needles/syringes with bleach before using.
Conclusions: Effective HIV prevention and care programmes for IDUs in Northeast India may hinge on several
enabling contexts: supportive government policy on harm reduction programmes, including in prisons; an end to
harassment by the police, army, and anti-drug groups, with education of these entities regarding harm reduction,
creation of partnerships with the public health sector, and accountability to government policies that protect IDUs’
human rights; adequate and sustained funding for NSPs to cover all IDU populations, including prisoners; and non-
discriminatory access by IDUs to affordable needles/syringes in pharmacies.
Background
Injecting drug users (IDUs) are among the highest prior-
ity subpopulations for HIV prevention identified by the
National AIDS Control Organization (NACO) in India
[1]. Sexual transmission is the primary route of HIV
transmission across India. In Northeast India, however,
injecting drug use is the major route of HIV transmission
[2]. Manipur, a small state in Northeast India with a
population of about 2.3 million, is among the Indian
states with the highest HIV prevalence, with 1.39% of
women attending antenatal clinics found to be HIV-
infected [3]. The cumulative number of HIV-positive
cases reported in Manipur from the start of the epidemic
to May 2008 was 29,602 cases; of these, 42.1% were cate-
gorized as having contracted HIV through injecting drug
use (personal communication with Manipur State AIDS
Control Society, 2008). In 1998, the estimated number of* Correspondence: p.newman@utoronto.ca2University of Toronto, Factor-Inwentash Faculty of Social Work, 246 Bloor
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IDUs in Manipur was 15,000-20,000 [4]; estimated HIV
seroprevalence among IDUs in 2006 was 19.8% [3].
Manipur lies adjacent to the Golden Triangle, where
the borders of Myanmar, Laos and Thailand meet; most
of its eastern boundary is formed by Myanmar, the sec-
ond largest opium producer in the world [5]. Manipur is
on a major drug-trafficking route from the Golden Tri-
angle; thus, illicit drugs are commonly available. Heroin,
locally known as “number four” among IDUs, is consid-
ered to be the major injecting drug used in Manipur
[6,7], although a powder form of dextropropoxyphene
(from capsules) is also increasingly used by IDUs for
injection [8,9].
Insurgency movements in Manipur and a “cold war”
among ethnic groups (such as Meitei, Kuki, Paite and
Naga) intermittently erupt in violent clashes [10,11]
involving the government and 39 armed militant groups
[12]. These have led to strict law enforcement by police
and a strong military and paramilitary presence in
Manipur [11,13,14]. In India, narcotic substances, such
as opium, coca leaf and psychotropic substances speci-
fied in the Narcotic Drugs and Psychotropic Substances
(NDPS) Act of 1985, are illegal. We have previously
documented police interference in HIV prevention and
care programmes among IDUs in Manipur [13].
Despite the epidemic among IDUs in Manipur and the
government’s focus on HIV prevention among this
population, there has been limited investigation in
Manipur of IDUs in general, or of HIV-positive IDUs, in
particular. Risk behaviours among HIV-positive IDUs
pose dangers to themselves, including hepatitis B virus
(HBV) and hepatitis C virus (HCV) infection, re-infec-
tion with new HIV and HCV subtypes, and super-infec-
tion with antiretroviral drug-resistant HIV strains, as
well as dangers of transmission of HIV, HBV and HCV
to their sexual and drug-using partners. In fact, extre-
mely high rates of HBV (100%) and HCV (92%) infec-
tion have been documented among HIV-positive IDUs
in Manipur [15].
In the town of Churachandpur in Manipur, 98% of a
sample of 191 IDUs were found to be infected with
HCV and 75% to be HIV seropositive; only 7% were
aware of their serostatus [6]. Most IDUs in this study
(93%) reported having shared injecting equipment, while
a rapid situation assessment study reported that 86% of
IDUs (n = 308) in the city of Imphal, Manipur had ever
shared syringes [16]. We know of no quantitative studies
in Manipur, and few in India [17], that have reported on
drug-related risk behaviours among IDUs by serostatus
or by knowledge of serostatus.
While identifying individual-level risk behaviours and
risk correlates is important, it is also crucial to explore
social, economic and political factors that interact with
and shape individual risk behaviours [18,19]. Several
investigators have presented evidence that HIV preven-
tive interventions for IDUs that focus only on individual
behaviour change are likely to result in only partial
reduction of HIV transmission risk [20-23]. Studies
from many countries, such as Russia, the United States,
United Kingdom, and Vietnam, have documented the
importance of understanding various contexts of drug
use related risk behaviours among IDUs [24-28]. In a
recent comprehensive review of international literature
on HIV risk among IDUs, factors identified as critical in
the social structural production of risk included: cross-
border trade and transport links; population movement
and mixing; urban or neighbourhood deprivation and
disadvantage; specific injecting environments such as
prisons; social stigma and discrimination; policies, laws
and policing; and complex emergencies such as armed
conflict [29]. With the exception of our own work [13],
we are not aware of any published studies among IDUs,
including HIV-positive IDUs, in India that examine in
depth the social-structural contexts of drug use related
risk behaviours and how they may influence individual-
level behaviours. Understanding social and structural
influences on unsafe injecting drug use behaviours
among HIV-positive IDUs is vital to support empirically
based preventive interventions.
In the present study, we examined injecting drug use
behaviours among HIV-positive IDUs in Imphal,
Manipur, with a focus on the social-structural contexts
of unsafe drug use and needle/syringe sharing and how
these contextual factors shape individual’s injecting risk
behaviours.
Methods
We conducted an integrated mixed methods investiga-
tion among HIV-positive IDUs in Imphal, including a
cross-sectional quantitative survey, focus groups, and in-
depth interviews. We also conducted key informant
interviews with physicians treating people living with
HIV (PLHIV). Data for the present study were collected
as part of a larger study focused on sexual and repro-
ductive health, as well as drug-related risk behaviours,
of various subpopulations of PLHIV, one of which was
IDUs in Manipur.
Sampling and recruitment
IDUs were defined as persons who injected drugs in the
3 months before the study interview or focus group, in
line with NACO’s definition [30]. Other eligibility cri-
teria were being HIV-positive for at least one year; 18
years of age or older; sexually active in the past 3
months; and able to understand and give informed
consent.
Survey participants were a convenience sample
recruited primarily from the Manipur Network of
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People living with HIV (MNP+); some were recruited
from other non-governmental organizations (NGOs)
that provide prevention and treatment services to IDUs
in Imphal. We recruited HIV-positive IDUs for the in-
depth interviews and focus groups from the same orga-
nizations. We used purposive sampling to ensure inclu-
sion of IDUs from diverse subpopulations, such as
married and single males and those who were co-
infected with HBV and/or HCV.
Data collection and analysis
For the cross-sectional quantitative survey, an inter-
viewer-administered structured questionnaire was used
to assess sociodemographic characteristics, alcohol and
substance use, HIV testing and treatment, sexual beha-
viour and condom use, family planning and reproductive
health, and sexually transmitted infections (STIs). This
report focuses on sociodemographic characteristics (age,
education, employment status, income, marital status
and living arrangements) and alcohol and substance use.
Participants were asked whether they had consumed
alcohol in the past 3 months; those who reported any
alcohol use were asked about days per week of alcohol
use and drinks per day on the days they drank. Sub-
stance use measures included: ever used recreational
drugs or injecting drugs, type of drugs used in the past
3 months, sharing of needles or syringes (yes/no) in the
past 30 days, and exchange of sex for drugs/money (yes/
no) in the past 30 days.
The survey questionnaire was drafted in English,
translated into Manipuri, back-translated into English,
and then finalized in Manipuri to ensure accuracy. Parti-
cipants were interviewed in private rooms in the office
of MNP+ or in other locations (such as participant’s
home) that were agreeable to both participants and
interviewers and where privacy was assured. The average
time to answer all questions was 40 minutes. Results
were described using means (± standard deviation) and
proportions, by gender.
For the qualitative component, we used topic guides
for data collection. Topic guides for the in-depth inter-
views and focus groups explored methods of injecting
drug use, contexts in which needle/syringe sharing or
any other unsafe injecting drug use behaviours occurred
after HIV diagnosis, risk reduction strategies adopted to
prevent risk of HIV transmission to others, and barriers
faced by participants in obtaining or using sterile nee-
dles/syringes. The topic guide for key informant inter-
views focused on barriers to and facilitators of safer sex
and safer injecting drug use among PLHIV, and avail-
ability and quality of prevention and treatment services
for PLHIV in government hospitals in Imphal. Indivi-
dual interviews were about 45 to 60 minutes in duration
and focus groups about 1.5 to 2 hours. All participants
in the quantitative survey, in-depth interviews, and focus
groups were given an honorarium of 250 Indian rupees.
Key informants were not paid.
All individual interviews, focus groups and key infor-
mant interviews were audiotaped, transcribed verbatim
in Manipuri, and then translated into English for data
analysis. We explored interview and focus group data
using a narrative thematic approach with techniques
adapted from grounded theory [31,32]. Initial themes
were identified using line-by-line coding. Themes were
then listed, compared and contrasted by three indepen-
dent researchers using a method of constant comparison
[33]. We discussed the findings and interpretations at a
community meeting with the field research team and
IDU representatives as a form of member checking.
Ethics and consent
The study protocol was reviewed and approved by the
Research Ethics Board of University of Toronto and the
Community Advisory Board of Indian Network for Peo-
ple living with HIV/AIDS. All participants provided
informed consent. No names or any other personal
identifying information was collected, and all personal
identifiers were removed when audiotapes were
transcribed.
Results
Characteristics of the participants
Survey
We surveyed a total of 75 IDUs, 50 males and 25
females. The mean age of participants was 35.6 ± 5.8
years for males and 31.0 ± 7.6 years for females.
Seventy-six percent of men and 36% of women had
completed high school. Thirty-four percent of men were
unemployed, and 64% of women reported sex work as
their main occupation. Almost three quarters (71%) of
participants reported a monthly income of 3000 Indian
Rupees or less. Of 29 men who were currently married
and living with their wife, 38% reported that she was
HIV-positive. All 8 women who were currently married
and living with their husband reported that he was
HIV-positive.
In-depth interviews
We conducted in-depth interviews with 4 male and 3
female IDUs. Men ranged in age from 30 to 39 years
and women from 25 to 32 years. One man completed
high school, and two men and two women completed
elementary education. Three men were single and one
married; two women were single and one married. Two
men and one woman were unemployed. Two women
engaged in sex work. Two key informants were inter-
viewed, both of whom were physicians working with
PLHIV in Manipur; one worked in a government hospi-
tal and the other for a non-governmental organization.
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Focus groups
Two focus groups were conducted, one with men (n =
9) and one with women (n = 8). Men ranged in age
from 28 to 48 years and women from 25 to 37 years.
Six men completed high school and were currently mar-
ried and living with their spouse; one was unemployed.
Four women were illiterate; all but one engaged in sex
work; and half were currently married and living with
their spouse.
Injecting drug and alcohol use
All 75 survey participants injected drugs in the past 3
months, and most (n = 62; 83% of men and women)
injected drugs every day or most days of the week. All
participants injected heroin; methamphetamine was the
next most commonly injected drug (20% [n = 10] of
men; 8% [n = 2] of women). One-third of participants
(34% [n = 17] of men; 32% [n = 8] of women) reported
sharing a needle or syringe at least once in the previous
30 days. All 17 men and 3 of the 8 women (38%) who
reported sharing a needle or syringe reported sharing
with at least one person of unknown HIV serostatus.
Seventy-six percent (n = 13) of the men and all (n = 8)
of the women who reported sharing a needle or syringe
reported that they usually or always cleaned the needle
or syringe with bleach before sharing. Overall, 64% (n =
16) of women, but none of the men, reported exchan-
ging sex for drugs or money in the past three months.
Three-fourths (n = 12) of the women who exchanged
sex for drugs or money did so at least ten times.
Seventy-four percent (n = 37) of men and 88% (n = 22)
of women reported consuming alcohol in the past 3
months. Forty-four percent (n = 22) of men and 72% (n
= 18) of women consumed alcohol at least once a week;
12% (n = 6) of men and 44% (n = 11) of women con-
sumed alcohol daily.
Contexts of needle/syringe sharing behaviours
A variety of contextual factors emerged in the qualita-
tive data that helped to illuminate needle/syringe shar-
ing practices among HIV-positive IDUs.
Fear of harassment by police and anti-drug groups
Although carrying needles/syringes is not illegal, the
“stop-and-search” tactics of police lead IDUs to fear that
carrying needles/syringes will constitute evidence of
drug use, which is illegal, and subsequent detention by
police under false charges. As a male participant
explained:
While I was carrying a syringe in my pocket...I ran
into some policemen frisking on the road. They
found me with the syringe...they knew I was a drug
user. They detained me and tried to take me
to a police station. Luckily...I was let free. Then
afterwards, whenever I go for drugs I never carry
syringes...whatever is available at the drug peddler’s
place I use it. ...that is how I started sharing needles
and syringes with other people.
A key informant confirmed that IDUs are often
arrested by police if they are found with syringes:
[Police] know people who are drug users since they
may have caught them earlier. So frisking them
becomes a routine. If they are found with syringes
then they are asked for money [by police]. If they
can’t pay, they arrest them on some false charges.
IDUs face what they described as harassment from
self-professed “anti-drug” pressure groups, in addition to
the police. This harassment deters many IDUs from car-
rying needles/syringes with them. As expressed by a
male IDU:
I am also one of the drug users who share needles
and syringes. Due to fear of organizations such as
[....], I do not want to take the risk of carrying a syr-
inge on my own. So it is better to go to the drug
peddler’s spot and whatever syringes are available at
the spot, I use them.
A key informant described some of these anti-drug
groups as ‘"parallel police” that stop and search sus-
pected IDUs on the street:
Anti-drug groups or pressure groups stop and search
people whom they suspect to be drug users - acting
as a parallel-police. They also ask drug users -
including youth and students - to confess in newspa-
pers that they are drug users. Previously they used to
even shoot them in the thighs...Thus they are almost
like ‘anti-drug user’ groups.
Using injecting drugs in drug dealers’ place of business
(usually their home or sometimes an abandoned building):
Risky micro-environment
Lack of sterile syringes in the drug dealer’s place of busi-
ness. Barriers to carrying clean needles/syringes, includ-
ing fear of arrest, constrain IDUs to use unclean
needles/syringes available in a drug dealers’ business
place, usually their home.
According to a male IDU:
In my locality drugs are easily available. Very near to
this drug peddler’s house....there was also a police
station. For me, it is not only that the police will
catch me but also my negligence. As a result I did it
[with used needles/syringes] on the [drug dealer’s]
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spot. Due to my withdrawal symptoms there even
was a time when I injected it with someone’s blood
inside that syringe. And there was a time when my
syringe fell inside the latrine and I took it out and
injected with it. All these things are due to my negli-
gence....my first priority is always given to drugs.
Thus, the severity of withdrawal symptoms, absence of
sterile needles/syringes in the drug-peddler’s house, and
fear of being arrested by police led to the use of unclean
needles/syringes in the drug-peddler’s house.
Drug-dealers do not allow drugs to be taken out of
their place of business Drug peddlers almost always
require IDUs to inject drugs at the location where they
are sold, fearing that the police might learn of their
business if IDUs were caught possessing their drugs. A
male IDU explained: “I went to the spot but the ped-
dlers were not allowing me to take drugs away; instead
they insisted that it had to be done at the spot...I did it
with the [used] syringe available there.”
A male IDU described how he was compelled by the
situation to share syringes with other users who were at
the drug dealer’s place:
If I [inject] at my home, I use the syringes we take
from the NGO. But when we go to buy drugs we
face tight security both from [police] commandos
and the army. So I don’t take syringes with me. And
I can’t come out with drugs from the house of the
[drug] peddler. We [inject] with whatever syringe
others [users] give us there.
Limited access to needles/syringes from pharmacies and
needle and syringe programmes (NSPs.)
In Manipur, needles/syringes are sold in pharmacies.
Although some IDUs reported that they buy needles/
syringes from pharmacies, others reported that they
have had a hard time convincing pharmacists to sell
them needles/syringes. As a male IDU noted: “...most of
the time, pharmacists are very strict; so we hardly buy
syringes from the pharmacy. So we buy one syringe and
we use it several times.”
Participants described fear of being identified as an
IDU by the pharmacist as a deterrent to buying needles/
syringes from pharmacies. A male IDU said, “We are
worried about buying syringes...[the pharmacist] might
expose to other people that we are drug users. For this
reason, we use old syringes.” A female IDU explained:
“We feel shy to ask for needles from a medical shop.
They will ask so many irrelevant questions.”
Some IDUs go to remote areas for injecting drugs,
where there is no access to pharmacies from which
they can buy needles/syringes. According to one male
IDU, “We sometimes inject on top [of the hills]...to
avoid police. To get a clean syringe there is not
possible.”
Some participants described up to tenfold mark-ups in
the regular price of needles/syringes from pharmacists.
A male IDU explained:
...if the syringe is five Rupees then the pharmacists
will sell it anywhere from 20 to 50 Rupees [about
one U.S. dollar, or about half a day’s wage]. They
will come to know you are asking for syringes for
injecting drugs since you are buying it from them
regularly and sometimes in bulk.
Several IDUs described not having any money left
after buying drugs and thus being unable to purchase
clean needles/syringes. A male IDU said, “After buying
drugs, there would not be even one paisa [penny] left in
our hands. In that case we have to use old syringes...” A
female IDU reported, “We know we should not share
syringes. A new syringe from the pharmacy shop is a
costly affair. Who will give extra money for a syringe as
such drugs are too costly?”
Finding money for buying drugs alone is a daunting
task for IDUs, given their low income level. This is espe-
cially true for women who inject drugs as they may need
to support their children and even other family mem-
bers. Consequently, many women engage in sex work to
obtain money to buy drugs, as shown in our quantitative
survey. In this context, buying clean needles/syringes
becomes an even more challenging proposition. As a
female IDU explained:
One shot [of drugs] costs 50 Rupees...if there is no
source of income then naturally for a woman this
[sex work] is the easiest way to earn money...in such
case she may not be interested in buying a clean syr-
inge every time.
In Imphal city, Manipur, NSPs have been implemen-
ted by NGOs for several years. However, the absence of
adequate and consistent funding from donors means
that only a fraction of IDUs are covered. Consequently,
some IDUs are not even aware of these programmes,
especially when they reside or inject drugs in areas not
covered by a program. A young woman who had
recently shared syringes was surprised to hear about
NSPs. She said, “What is it? I do not know. I never hear
about it...It will be very nice if somebody could give me
new syringes. Who will be happy in always cleaning and
washing?”
Even those IDUs who have been receiving sterile nee-
dles/syringes from NSPs may not obtain an adequate
number of clean needles/syringes; the supply may
not match their demand, especially if they are high
Chakrapani et al. Harm Reduction Journal 2011, 8:9
http://www.harmreductionjournal.com/content/8/1/9
Page 5 of 10
frequency users. A high frequency of injecting drug use
also discourages IDUs from buying clean needles/syr-
inges. A male IDU said, “I take [inject] almost daily;
I could not also spend money for new syringes daily...
Yes, I pick up some [syringes] at NGOs.” High fre-
quency of injecting drug use together with lack of
money to pay for sterile needles/syringes and inadequate
sterile needle/syringe availability from NGOs promote
syringe/needle sharing among HIV-positive IDUs.
Unavailability of sterile needles/syringes within prisons
IDUs often end up in prison, sometimes due to actions
of their own families. Some IDUs steal from their own
home to purchase drugs. As a former prison inmate
said, “Once I took some utensils from [my] home and
sold them to buy drugs. Then I used to take other mate-
rials also. My family became suspicious and one day
they found cotton and needles in my pocket. Then I
told them the truth. They filed a case and sent me to
jail to stop me from using drugs.” A physician key infor-
mant related that family members often ask police to
file false cases to send their drug-using sons to prisons
in the hope that their sons will give up the “drug habit.”
Furthermore, he said that while some families are sup-
portive and want to enrol their sons in drug dependence
treatment centres, others disown them.
Lack of availability of sterile needles/syringes inside
prisons, in spite of the availability of injecting drugs in
prisons, means that sharing of needles/syringes among
inmates is common. As a male IDU who had spent time
in prison explained:
Inside the jail I met many of my friends. I somehow
got money from my family and I started using it
[drugs] inside the jail. Outside the jail I never shared
syringes with others...inside the jail we do not have
syringes; the police sold them for 100 rupees [more
than 2 U.S. dollars) per syringe. So if I buy a syringe
then I can get drugs free of cost [from friends who
buy drugs]. In this way, we started sharing a syr-
inge...sometimes we shared it after cleaning with
bleach water...when police asked we told them that
we used it for washing clothes.
Thus, this HIV-positive man and his fellow drug users
in prison tried to reduce the risk of HIV transmission
by procuring and using bleach to clean syringes.
Risk reduction strategies adopted by HIV-positive IDUs
In spite of the variety of contextual factors that lead
to needle/syringe sharing, some HIV-positive IDUs
reported having adopted strategies to reduce the risk of
HIV transmission to other IDUs - even if they share
needles/syringes with others.
Being the ‘last receiver’ of needles/syringes and not a ‘giver’
In general, participants felt that there was a silent ‘don’t
ask, don’t tell’ policy - with no one telling or asking
other drug users’ HIV status. As a man said, “I always
get syringes from others...I don’t give...No, they [co-
injectors] do not know [my HIV status].” In spite of
nondisclosure of HIV status to other IDUs, this partici-
pant tried to avoid HIV transmission by being the ‘last
receiver.’
Some IDUs reported using disclosure of HIV status as
an additional strategy along with being the ‘last receiver’
of the shared needles/syringes. As a female IDU said,
“I always tell my [HIV] status to my [women] friends.
So I prefer to be the last one to inject drugs.” Similarly
a male IDU said, “I did not know their status in the
drug peddler’s place...[but] I have always told them
about my status. I let them inject first.” This participant
disclosed his HIV-positive status in a drug dealer’s place
in spite of the potential negative consequences such as
discrimination and isolation from other users. In the
community meeting and debriefing following data col-
lection, IDUs suggested that most IDUs know that the
majority of IDUs in Manipur are HIV-positive; thus
other IDUs would not be shocked or react negatively
even if some IDUs “announce it [HIV-positive status] in
a public area using a loudspeaker.”
Asking others to wash used needles/syringes with bleach
Recognizing that he could transmit HIV to co-injectors
in the drug dealer’s place, a man who usually did not
disclose his HIV-positive status said, “I insist [other
IDUs] to wash with bleach or water if I used the syringe
first...I got this [HIV] because someone did not ask me
to do so [wash syringes]...” Similarly, a male IDU who
had spent time in prison reported using bleach along
with his fellow prisoner drug users to clean syringes in
order to prevent HIV transmission (see above).
’Serosorting’: Sharing needles/syringes only with other
HIV-positive IDUs
Some HIV-positive IDUs share needles/syringes only
with other known HIV-positive IDUs. As a male IDU
said, “I give my used syringe to friends who are already
[HIV-] positive.”
Similarly a female IDU said that she had recently
shared needles/syringes only with other female IDUs
who are HIV-positive. The reasoning behind this ‘sero-
sorting’ is the assumption that needle/syringe sharing
between HIV-positive IDUs is not harmful, whereas they
otherwise risk transmitting HIV to HIV-negative IDUs.
Although these risk reduction strategies used by HIV-
positive IDUs may prevent or reduce HIV transmission
to others, they place HIV-positive IDUs at greater risk
of contracting HBV and HCV, as well as new HCV and
HIV subtypes.
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Withdrawal symptoms supersede concern for health
Many HIV-positive IDUs attributed sharing of or using
unclean needles/syringes to the severity of their drug
withdrawal symptoms. When their withdrawal symp-
toms begin, their need for the drug supersedes all other
concerns, even as they may have knowledge of infection
risks. A male IDU reported:
I know that one syringe costs only five rupees. Even
though I can get them free of cost from DIC [drop-
in centre of non-governmental organizations], during
my withdrawal I go directly to the [drug dealer’s]
spot and [I use] whatever syringes are available -
they are mostly already used ones. Everyone washes
it with water - we did not wash it properly. It does
not mean we did not realize what we have done, but
the realization comes only after we had drugs.
A similar explanation was given by another man:
It [syringe sharing] is mainly due to our withdrawal
symptoms ...at that very moment we forget about
disease [HIV]. As a result, we are not afraid of tak-
ing the risk.
Thus, the severity of withdrawal symptoms may lead
IDUs to prioritize immediate symptoms over long-term
health.
Discussion
A large proportion of HIV-positive IDUs in the present
survey, conducted in Imphal city, Manipur, have
adopted safer injecting drug use behaviours and do not
share needles/syringes with others. However, about one-
third of HIV-positive IDUs reported sharing needles/syr-
inges at least once in the previous 30 days.
Overall, our qualitative findings illustrate how social,
legal, economic, and policy contexts influence and shape
individual-level injecting drug use risk behaviours of
HIV-positive IDUs. Successful and effective HIV preven-
tion and care programmes for IDUs in Northeast India
may be contingent on several enabling contexts: suppor-
tive government policies on harm reduction, including
in prisons; an end to harassment by the police, army,
and anti-drug groups, with a combination of education
for these entities about harm reduction, creation of part-
nerships with the public health sector, and accountabil-
ity to government policies that protect IDUs’ human
rights; adequate funding for NSPs to cover all IDUs in
an intervention area, including those who are HIV-posi-
tive, and IDUs in prisons; non-discriminatory access by
IDUs to affordable needles/syringes in pharmacies; and
family and societal acceptance of IDUs, including those
who are HIV-positive, through family counselling and
public sensitisation campaigns. Our focus groups and
individual interviews with IDUs, and key informant
interviews, indicated that many of these enabling con-
textual factors are not in place.
Buying and carrying sterile needles/syringes are not
criminal activities in India [34]; however, laws crimina-
lizing use and possession of even small amounts of
recreational drugs and stringent measures taken by the
police drive many IDUs underground. Many IDUs avoid
buying and carrying sterile needles/syringes as posses-
sion of a needle/syringe is often taken as evidence of
drug use. Studies from several other countries similarly
document reluctance among IDUs to buy and carry nee-
dles/syringes due to the legal context and stringent poli-
cing practices [24,35-40]. The concentrated presence of
the Indian army in Manipur due to insurgency and eth-
nic conflicts increases the chances that IDUs may be
“frisked” and then detained if any evidence of drug use
is found [13]. Similarly, drug dealers’ fear of being
caught by the police results in their not allowing IDUs
to take drugs off site. Consequently, IDUs are forced to
inject drugs at the dealers’ locales with whatever nee-
dles/syringes are available, which results in sharing nee-
dles/syringes with others.
The easy availability of drugs in Manipur, a major
drug trafficking route, and ongoing political insurgency,
have led many NGOs ostensibly focused on develop-
ment to adopt drug use and prevention as their primary
goals, and to form alliances as anti-drug pressure
groups. Furthermore, drug trafficking is allegedly a
source of funding for some of the insurgency groups;
thus combating the drug trade also serves political and
military goals [41,42]. From the perspectives of partici-
pants and key informants, the actions of many NGOs
and anti-drug groups often serve to produce risk by
fomenting criminalization and rigid abstinence-only
approaches thereby targeting drug users themselves.
Although there are free NSPs in Manipur, lack of ade-
quate and consistent funding hinders these programmes
from providing coverage to all IDUs who need them. In
spite of the Indian government’s recent changes in pol-
icy that now allow NSPs, delays in scaling up these pro-
grammes and failure to ensure uninterrupted funding to
the NGOs that run them ultimately result in unsafe
injecting drug use practices among IDUs. Furthermore,
the same fear of detainment or arrest that prevents
IDUs from carrying clean needles/syringes may deter
utilization of NSPs. IDUs report being detained by
police as they leave NSPs carrying syringes [13].
Pharmacies are another venue through which clean
needles/syringes may be accessed; however, fear of
being identified as an IDU prevents many IDUs from
buying sterile needles/syringes in pharmacies. Addi-
tionally, pharmacists sometimes discriminate against
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IDUs by inflating the price of syringes, making them
unaffordable.
There appears to be a confluence of factors–poverty,
high costs of recreational drugs, criminal laws, harass-
ment from anti-drug groups and police, and restrictive
governmental policy on NSPs in prisons–that renders
many IDUs particularly vulnerable to HIV and co-infec-
tions. Most IDUs are unemployed or have low-wage
jobs. In the absence of support from family members,
some IDUs engage in criminal activities in order to buy
drugs, including stealing from their own families, which
in turn may land them in prison-sometimes through the
direct intervention of family members [13]. Although
injecting drugs may be available in prisons, at even
higher prices, it is very difficult to access sterile needles/
syringes in prisons [13]. Consequently, many IDUs in
prison, including those who are known to be HIV-posi-
tive, may be forced to share needles/syringes with
others. Drug use in Indian prisons has been acknowl-
edged by the Indian government [43]. However, India
does not have government-sponsored NSPs or opioid
substitution treatment programmes within prisons,
which increases the spread of HIV and negatively affects
the health of HIV-positive IDUs in prisons.
The most frequently cited individual-level reason for
unsafe injecting drug use behaviours was the severity of
drug withdrawal symptoms, which led many IDUs to
prioritize immediate symptoms over long-term health.
Thus, it is crucial to assist HIV-positive IDUs to treat
their chemical dependency by linking them to drug sub-
stitution therapy (sublingual buprenorphine or metha-
done solution) and/or to drug dependence treatment
programmes. NACO is presently scaling up sublingual
buprenorphine substitution therapy in the third phase of
the National AIDS Control Program (NACP-3) (2007-
2012). Although methadone is currently illegal in India,
NACO also has plans to ‘pilot’ methadone maintenance
clinics soon [44]. This scale up should be implemented
rapidly. Furthermore, methadone substitution therapy,
which is not currently available in public hospitals in
India, should be made available.
On the individual level, the emphasis of risk-reduction
counselling for HIV-positive IDUs needs to be on avoid-
ing needle/syringe sharing and always using clean nee-
dles/syringes. Harm reduction messages should stress
not only the need to avoid risk of HIV transmission
to others, but also the risk of contracting new HIV
infections, including different HIV subtypes and drug-
resistant strains, as well as HBV and HCV infection.
However, given powerful contexts that constrain IDUs’
enactment of HIV risk reduction behaviours, this coun-
selling should be seen as only one of the steps towards
providing holistic and comprehensive care to HIV-posi-
tive IDUs.
A limitation of this study was the use of a conveni-
ence sample of HIV-positive IDUs in the survey. Partici-
pants, who were recruited through MNP+ and other
NGOs providing services to IDUs, may engage in safer
injecting practices than HIV-positive IDUs who are not
connected to services; risk behaviours among other
HIV-positive IDUs may be even greater. Furthermore,
social desirability bias may have led some participants to
underreport their needle/syringe-sharing behaviours.
Thus, our finding that one-third of HIV-positive IDUs
shared needles/syringes may represent an underestimate.
The small number of in-depth interviews and key infor-
mant interviews also represents a limitation in that we
cannot ensure saturation; other participants might intro-
duce perspectives and opinions not addressed by those
who we interviewed. However, we triangulated methods
(survey, in-depth interviews and focus groups) and data
sources (IDU participants and key informants) to
increase the validity of the findings [31].
Finally, although we identified the practices of “sero-
sorting” in needle/syringe sharing and being the ‘last
receiver’ of needles/syringes among HIV-positive IDUs
in the qualitative component of this study, we did not
measure the prevalence of these practices in the survey.
Future research among IDUs should assess the preva-
lence of these practices among known HIV-positive and
known HIV-negative IDUs. IDUs also should receive
education to the effect that serosorting is not a fool-
proof strategy: knowledge of one’s drug-using partners’
serostatus may be flawed, and HCV and HBV may be
transmitted regardless of HIV status.
Conclusions
We identified a variety of powerful social, legal, eco-
nomic, and policy-level factors that create a context in
which HIV-positive IDUs in Manipur who might
otherwise adopt safer injecting practices instead
engage in needle/syringe sharing. Nevertheless, many
of these contextual factors are modifiable. In addition
to enhancing interventions that focus on risk reduc-
tion at the individual level, it is crucial to undertake
broader structural interventions to address key con-
textual factors in India that, albeit unintentionally,
contribute to HIV risk among IDUs. Ultimately, these
higher-level interventions hold the promise of effect-
ing sustainable reduction of HIV infections among
IDUs and for improving the health of IDUs living with
HIV in India.
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